TY - JOUR
T1 - Undifferentiated pleomorphic sarcoma around the kidney
T2 - A case report
AU - Murakami, Michihiro
AU - Hara, Chiaki
AU - Yamanaka, Kotaro
AU - Yamaguchi, Takahiro
AU - Tanoue, Kenichiro
AU - Kurahashi, Ryoma
AU - Fukushima, Yumi
AU - Motoshima, Takanobu
AU - Murakami, Yoji
AU - Yatsuda, Jyunji
AU - Sugiyama, Yutaka
AU - Nishi, Kazuhiko
AU - Kanba, Tomomi
AU - Eto, Masatoshi
N1 - Publisher Copyright:
© 2020 The West Japan Urological Association. All rights reserved.
PY - 2020/8
Y1 - 2020/8
N2 - A 58-year-old man was incidentally found to have a left retroperitoneal tumor by computed tomography (CT) during a comprehensive health check-up and he was referred to our hospital. Enhanced CT revealed a perirenal mass located in the upper pole of the left kidney. It was diagnosed as undifferentiated/unclassified sarcoma by CT-guided needle biopsy. Laparoscopic radical nephrectomy was performed and the pathological diagnosis was undifferentiated pleomorphic sarcoma (UPS). Since the resected margin was positive, we performed adjuvant chemotherapy with doxorubicin and ifosfamide. Thereafter, the patient decided for himself to receive immunotherapy at another hospital. Unfortunately, the tumor later relapsed. Although the recurrent tumor was removed by open surgery, the resected margin was again positive. Postoperatively, the patients refused adjuvant chemotherapy and continued to receive immunotherapy. The patient then developed multiple metastases and received pazopanib which produced a temporary tumor shrinkage effect, but finally he died of disease progression.
AB - A 58-year-old man was incidentally found to have a left retroperitoneal tumor by computed tomography (CT) during a comprehensive health check-up and he was referred to our hospital. Enhanced CT revealed a perirenal mass located in the upper pole of the left kidney. It was diagnosed as undifferentiated/unclassified sarcoma by CT-guided needle biopsy. Laparoscopic radical nephrectomy was performed and the pathological diagnosis was undifferentiated pleomorphic sarcoma (UPS). Since the resected margin was positive, we performed adjuvant chemotherapy with doxorubicin and ifosfamide. Thereafter, the patient decided for himself to receive immunotherapy at another hospital. Unfortunately, the tumor later relapsed. Although the recurrent tumor was removed by open surgery, the resected margin was again positive. Postoperatively, the patients refused adjuvant chemotherapy and continued to receive immunotherapy. The patient then developed multiple metastases and received pazopanib which produced a temporary tumor shrinkage effect, but finally he died of disease progression.
UR - http://www.scopus.com/inward/record.url?scp=85096320034&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096320034&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85096320034
SN - 0029-0726
VL - 82
SP - 391
EP - 396
JO - Nishinihon Journal of Urology
JF - Nishinihon Journal of Urology
IS - 3
ER -